BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Magri J, Gasparetto A, Conti L, Calautti E, Cossu C, Ruiu R, Barutello G, Cavallo F. Tumor-Associated Antigen xCT and Mutant-p53 as Molecular Targets for New Combinatorial Antitumor Strategies. Cells 2021;10:108. [PMID: 33430127 DOI: 10.3390/cells10010108] [Cited by in Crossref: 1] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhang J, Gao M, Niu Y, Sun J. Identification of a Novel Ferroptosis Inducer for Gastric Cancer Treatment Using Drug Repurposing Strategy. Front Mol Biosci 2022;9:860525. [DOI: 10.3389/fmolb.2022.860525] [Reference Citation Analysis]
2 Ruiu R, Di Lorenzo A, Cavallo F, Conti L. Are Cancer Stem Cells a Suitable Target for Breast Cancer Immunotherapy? Front Oncol 2022;12:877384. [PMID: 35530300 DOI: 10.3389/fonc.2022.877384] [Reference Citation Analysis]
3 Li S, Lei Z, Yang X, Zhao M, Hou Y, Wang D, Tang S, Li J, Yu J. Propofol Protects Myocardium From Ischemia/Reperfusion Injury by Inhibiting Ferroptosis Through the AKT/p53 Signaling Pathway. Front Pharmacol 2022;13:841410. [DOI: 10.3389/fphar.2022.841410] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Mattei F, Alfaro C, Keisari Y. Cancer Immunology: From Molecular Mechanisms to Therapeutic Opportunities. Cells 2022;11:459. [DOI: 10.3390/cells11030459] [Reference Citation Analysis]
5 Dabbour NM, Salama AM, Donia T, Al-deeb RT, Abd Elghane AM, Badry KH, Loutfy SA. Managing GSH elevation and hypoxia to overcome resistance of cancer therapies using functionalized nanocarriers. Journal of Drug Delivery Science and Technology 2022;67:103022. [DOI: 10.1016/j.jddst.2021.103022] [Reference Citation Analysis]
6 Umans RA, Martin J, Harrigan ME, Patel DC, Chaunsali L, Roshandel A, Iyer K, Powell MD, Oestreich K, Sontheimer H. Transcriptional Regulation of Amino Acid Transport in Glioblastoma Multiforme. Cancers (Basel) 2021;13:6169. [PMID: 34944790 DOI: 10.3390/cancers13246169] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
7 Sniegowski T, Korac K, Bhutia YD, Ganapathy V. SLC6A14 and SLC38A5 Drive the Glutaminolysis and Serine-Glycine-One-Carbon Pathways in Cancer. Pharmaceuticals (Basel) 2021;14:216. [PMID: 33806675 DOI: 10.3390/ph14030216] [Cited by in Crossref: 3] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]